Literature DB >> 18778755

Iron, the substantia nigra and related neurological disorders.

Amanda M Snyder1, James R Connor.   

Abstract

BACKGROUND: Iron status is higher in the substantia nigra than in other brain regions but can fluctuate as function of diet and genetics and disease. Of particular note is the compartmentalization of the iron-enrichment in this region; the pars reticulata contains higher levels of stainable iron as compared to the pars compacta. The latter area is where the dopaminergic neurons reside. How this compartmentalization impacts the interpretation of data that iron contributes to cell death as in Parkinson's disease or iron deficiency contributes to altered dopaminergic activity is unknown. Nonetheless, that iron can influence neuronal cell death and dopamine function is clear.
METHODS: The mechanisms by which iron may be managed in the substantia nigra, particularly in the neuromelanin cells where minimal levels of ferritin the iron storage protein have been detected are addressed. The current approaches to detect iron in the substantia nigra are also reviewed. In addition, the potential mechanisms by which iron enrichment may occur in the substantia nigra are explored. GENERAL SIGNIFICANCE: This review attempts to provide a critical evaluation of the many avenues of exploration into the role of iron in one of the most iron-enriched and clinically investigated areas of the brain, the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778755     DOI: 10.1016/j.bbagen.2008.08.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.

Authors:  M Eapen; D H Zald; J C Gatenby; Z Ding; J C Gore
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

3.  Identification of a fluorescent general anesthetic, 1-aminoanthracene.

Authors:  Christopher A Butts; Jin Xi; Grace Brannigan; Abdalla A Saad; Srinivasan P Venkatachalan; Robert A Pearce; Michael L Klein; Roderic G Eckenhoff; Ivan J Dmochowski
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

4.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

5.  Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal, Autonomic, and Motor Systems.

Authors:  Marta Bianciardi; Nicola Toschi; Brian L Edlow; Cornelius Eichner; Kawin Setsompop; Jonathan R Polimeni; Emery N Brown; Hannah C Kinney; Bruce R Rosen; Lawrence L Wald
Journal:  Brain Connect       Date:  2015-08-11

6.  Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice.

Authors:  Pavle Matak; Andrija Matak; Sarah Moustafa; Dipendra K Aryal; Eric J Benner; William Wetsel; Nancy C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

7.  HFE polymorphisms affect survival of brain tumor patients.

Authors:  Sang Y Lee; Becky Slagle-Webb; Jonas M Sheehan; Junjia Zhu; Joshua E Muscat; Michael Glantz; James R Connor
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

8.  Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity.

Authors:  Yong Chen; Reas S Khan; Alyssa Cwanger; Ying Song; Catherine Steenstra; Sookhee Bang; Jaime H Cheah; Joshua Dunaief; Kenneth S Shindler; Solomon H Snyder; Sangwon F Kim
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

9.  Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.

Authors:  Nadia G Innamorato; Agnieszka Jazwa; Ana I Rojo; Concepción García; Javier Fernández-Ruiz; Anna Grochot-Przeczek; Anna Stachurska; Alicja Jozkowicz; Jozef Dulak; Antonio Cuadrado
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.